BMGP.US Biomagnetics Diagnos
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -35.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2013.
Is BMGP.US undervalued?
Graham numberThe Graham number of Biomagnetics Diagnos cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Biomagnetics Diagnos fundamental analysis
No fundamental analysis for Biomagnetics Diagnos yet.
Biomagnetics Diagnos stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Biomagnetics Diagnos
Biomagnetics Diagnostics Corp., a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include High Throughput Screening"Magnetic Testing Platform (HTS-MTP) to provide qualitative and quantitative results from a single test by detecting the target virus through measuring the magnetic field of micro-particles bonded to the virus in a fraction of the time; and Integrated Optical B…
Full company profileBiomagnetics Diagnos financial statements
2013 annualized: Fiscal year 2013 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2013, the balance sheet is the latest quarter. Figures change when the annual report is published.
Biomagnetics Diagnos annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -231K | -705K | -171K | -850K | -381K | -273K |
| Net Income | -327K | -1.17M | -238K | -865K | -518K | -292K |
| Balance Sheet | ||||||
| Total Assets | 72.0K | 559K | 1.67M | 1.44M | 1.29M | 1.18M |
| Total Liabilities | 668K | 590K | 235K | 202K | 311K | 353K |
| Shareholders' Equity | -596K | -30.7K | 1.43M | 1.24M | 977K | 822K |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 2.25K | 3.96K |
| Cash Flow | ||||||
| Operating Cash Flow | -117K | -318K | 900K | -347K | -197K | -80.4K |
| Capital Expenditure | 1.46M | 1.46M | 1.46M | 0.00 | 0.00 | 0.00 |
| Ratios | ||||||
| ROE | - | - | -16.6% | -69.9% | -53.0% | -35.5% |
| ROA | -454.6% | -209.7% | -14.3% | -60.1% | -40.2% | -24.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Biomagnetics Diagnos dividends
Biomagnetics Diagnos has not paid dividends in the last 5 fiscal years.
Last stock split: 1:250 on Mar 28, 2006.
Who owns Biomagnetics Diagnos
Ownership data of Biomagnetics Diagnos is not available yet.
Biomagnetics Diagnos company profile
- Company name
- Biomagnetics Diagnos
- Ticker
- BMGP.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Employees
- 2
- Fiscal year end
- December
- Address
- 8864 Greenback Lane, Orangevale, CA, United States, 95662
- Phone
- 916-987-7078
- Website
- biomagneticsbmgp.com
About Biomagnetics Diagnos
Biomagnetics Diagnostics Corp., a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include High Throughput Screening"Magnetic Testing Platform (HTS-MTP) to provide qualitative and quantitative results from a single test by detecting the target virus through measuring the magnetic field of micro-particles bonded to the virus in a fraction of the time; and Integrated Optical Biosensor System that is based on protein-receptor binding, which brings two or more optically tagged receptors into close proximity using planar optical waveguides, and triggers fluorescence changes identified by tiny on-board detectors. Biomagnetics Diagnostics Corp. has a licensing and collaborative research and development agreement with Las Alamos National Security LLC for Integrated Optical BioSensor. The company was founded in 1997 and is based in Orangevale, California.
Biomagnetics Diagnos management
3- Mr. Clayton M. HardmanFounder, CEO, President, Acting CFO, Secretary & Director · born 1944
- Mr. Paul Clayton HardmanChief Operating Officer
- Dr. Jose Manuel Lopez PortilloDirector and Director of Strategic Alliances & Government Affairs for Mexico